MeSH D012141 - respiratory tract infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012141:Â
Respiratory tract infections
D001991:Bronchitis
D003139:Common cold
D007251:Human influenza
D007827:Laryngitis
D007876:Legionellosis
D008169:Lung abscess
0 Companies
0 Drugs
Success rate
D008172:Fungal lung diseases
0 Companies
0 Drugs
Success rate
D008174:Parasitic lung diseases
0 Companies
0 Drugs
Success rate
D010612:Pharyngitis
D010998:Pleurisy
0 Companies
0 Drugs
Success rate
D011014:Pneumonia
D012220:Rhinitis
D012226:Rhinoscleroma
0 Companies
0 Drugs
Success rate
D012852:Sinusitis
D014136:Tracheitis
0 Companies
0 Drugs
Success rate
D014387:Laryngeal tuberculosis
0 Companies
0 Drugs
Success rate
D014396:Pleural tuberculosis
0 Companies
0 Drugs
Success rate
D014397:Pulmonary tuberculosis
D014917:Whooping cough
D016724:Pleural empyema
0 Companies
0 Drugs
Success rate
D045169:Severe acute respiratory syndrome
0 Companies
0 Drugs
Success rate
D048090:Bovine respiratory disease complex
0 Companies
0 Drugs
Success rate
D059525:Supraglottitis
0 Companies
0 Drugs
Success rate
D000092562:Allergic fungal sinusitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ampicillin | Ampicillin Trihydrate |  | 1982-01-01 |  |  |
| Gentamicin | Gentamicin |  | 1991-11-21 |  |  | |
| Oxacillin | Oxacillin |  | 1982-01-01 |  |  | |
| Tobramycin | Tobramycin |  | 1992-01-30 |  |  | |
| Padagis | Gentamicin | Gentamicin |  | 1982-01-01 |  |  |
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone |  | 2022-02-11 |  |  | |
| Taro Pharmaceutical | Gentamicin | Gentamicin |  | 1983-05-26 |  |  |
| Mylan | Ampicillin | Ampicillin Trihydrate |  | 1982-01-01 |  |  |
| Cefoxitin | Mefoxin |  | 1987-01-08 |  |  | |
| Tobramycin | Tobramycin |  | 2008-03-11 |  |  | |
| Viatris | Tobramycin | Tobi |  | 1997-12-22 |  |  |
| GSK | Oxacillin | Bactocill |  | 1982-01-01 |  |  |
| Nafcillin | Nallpen |  | 1982-01-01 |  |  | |
| Clavulanate, Ticarcillin | Timentin |  | 1986-12-19 |  |  | |
| Ampicillin | Totacillin |  | 1982-01-01 |  |  | |
| Ampicillin | Totacillin-n |  | 1982-01-01 |  |  | |
| Chartwell Pharmaceuticals | Ampicillin | Ampicillin Trihydrate |  | 1982-01-01 |  |  |
| Tobramycin | Tobramycin |  | 2001-09-11 |  |  | |
| Lupin Research | Tobramycin | Tobramycin |  | 2017-03-22 |  |  |
| Sandoz | Ampicillin | Ampicillin |  | 1982-01-01 |  |  |
| Ampicillin, Sulbactam | Ampicillin Sulbactam |  | 2006-07-25 |  |  | |
| Ampicillin | Ampicillin Trihydrate |  | 1995-08-29 |  |  | |
| Gentamicin | Gentamicin |  | 1982-01-01 |  |  | |
| Meropenem | Meropenem |  | 2011-03-29 |  |  | |
| Nafcillin | Nafcillin |  | 1984-08-02 |  |  | |
| Oxacillin | Oxacillin |  | 1982-01-01 |  |  | |
| Tobramycin | Tobrex |  | 1984-12-13 |  |  | |
| Dexamethasone, Tobramycin | Tobradex |  | 1988-08-18 |  |  | |
| Penicillin g | Penicillin G |  | 2001-02-26 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
67%20/30
Phase 2
47%18/38
Phase 3
59%47/80
Approved: 29Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use